Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Immunological approaches to HIV cure

Seminars in Immunology(2020)10.1016/j.smim.2020.101412Source: DataRank Database

Immunological approaches to HIV cure is a research paper published in Seminars in Immunology (2020). On theSindex it has a DataRank of 0. It has been cited 89 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access89 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)Topics (12)IDs (PubMed)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Talia M. Mota ORCID,R. Brad Jones ORCID,Adam R. Ward ORCID

Live enrichment

PubMed:32981836

National Institutes of Health

Grant: 1UM1AI26617

Office of AIDS Research

Grant: AI31798

Eunice Kennedy Shriver National Institute of Child Health and Human Development

National Cancer Institute

National Institute of Allergy and Infectious Diseases

National Institute on Drug Abuse

Fogarty International Center

National Institute of Mental Health

National Institute on Aging

Office for the Advancement of Research, John Jay College of Criminal Justice

National Heart, Lung, and Blood Institute

MeSH Terms

CD4-Positive T-LymphocytesHumansHIV-1HIV InfectionsAntiviral AgentsVirus Latency

Keywords

LatencyT-cellsBroadly Neutralizing AntibodiesHiv CureImmunotherapiesTarget-cell Immune Resistance

Related Papers (10)

Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo

Nature(2020)

co-cited

10.1038/s41586-020-1951-3

The Biology of the HIV-1 Latent Reservoir and Implications for Cure Strategies

Cell Host & Microbe(2020)

co-cited

10.1016/j.chom.2020.03.014

Robust and persistent reactivation of SIV and HIV by N-803 and depletion of CD8+ cells

Nature(2020)

co-cited

10.1038/s41586-020-1946-0

Curing HIV: Seeking to Target and Clear Persistent Infection

N/A

0.785DataRank · unranked

Cell(2020)

co-cited

10.1016/j.cell.2020.03.005

HIVconsv Vaccines and Romidepsin in Early-Treated HIV-1-Infected Individuals: Safety, Immunogenicity and Effect on the Viral Reservoir (Study BCN02)

N/A

0.672DataRank · unranked

Frontiers in Immunology(2020)

co-cited

10.3389/fimmu.2020.00823

Combination of CD8β Depletion and Interleukin-15 Superagonist N-803 Induces Virus Reactivation in Simian-Human Immunodeficiency Virus-Infected, Long-Term ART-Treated Rhesus Macaques

N/A

1.3DataRank · unranked

Journal of Virology(2020)

co-cited

10.1128/jvi.00755-20

The human IL-15 superagonist N-803 promotes migration of virus-specific CD8+ T and NK cells to B cell follicles but does not reverse latency in ART-suppressed, SHIV-infected macaques

N/A

0.626DataRank · unranked

PLoS Pathogens(2020)

co-cited

10.1371/journal.ppat.1008339

Assessing the impact of AGS-004, a dendritic cell-based immunotherapy, and vorinostat on persistent HIV-1 Infection

Scientific Reports(2020)

co-cited

10.1038/s41598-020-61878-3

Redirection of Cord Blood T Cells and Natural Killer Cells for Elimination of Autologous HIV-1-Infected Target Cells Using Bispecific DART® Molecules

Frontiers in Immunology(2020)

co-cited

10.3389/fimmu.2020.00713

Experimental Systems for Measuring HIV Latency and Reactivation

N/A

0.520DataRank · unranked

Viruses(2020)

co-cited

10.3390/v12111279